TSH-induced hyperthyroidism caused by a pituitary tumor

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 9, 2006, Pages 524-528

  Beck Peccoz, Paolo ^a,b   Persani, Luca ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Hyperthyroidism; Pituitary adenoma; Prolactin; Somatostatin analogs; TSH

Indexed keywords

ANGIOPEPTIN; ANTITHYROID AGENT; CABERGOLINE; CORTICOTROPIN; GLYCOPROTEIN; GONADOTROPIN; HYDROCORTISONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERECTILE DYSFUNCTION; FOLLOW UP; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SELLA TURCICA; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; VISUAL DISORDER;

ADENOMA; ANTITHYROID AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; OCTREOTIDE; PEPTIDES, CYCLIC; PITUITARY NEOPLASMS; SOMATOSTATIN; THYROTROPIN;

EID: 33748462269     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0276     Document Type: Article

References (15)

1. Beck-Peccoz P et al. (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17: 610-638
2. Yamakita N et al. (1995) Thyrotropin-producing pituitary adenoma discovered as a pituitary incidentaloma. Intern Med 34:1055-1060
3. Losa M et al. (1996) Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81: 3084-3090
4. Brucker-Davis F et al. (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84: 476-486
5. Socin HV et al. (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148: 433-442
6. Mannavola D et al. (2005) Different response to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol 62: 176-181
7. Beck-Peccoz P and Persani L (1994) Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 131: 331-340
8. Persani L et al. (1998) Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab 83: 2486-2492
9. Beck-Peccoz P et al. (1990) Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 71: 19-25
10. Persani L et al. (1997) Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Clin Endocrinol (Oxf) 47: 207-214
11. Pasquini E et al. (2003) Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. Eur J Endocrinol 148: 253-257
12. Watanabe K et al. (1993) Thyrotropin-producing adenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 76: 1025-1030
13. Ando S et al. (2001) Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86: 5572-5576
14. Chanson P et al. (1993) Octreotide therapy for thyroid stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119: 236-240
15. Kuhn JM et al. (2000) Evaluation of the treatment of thyrotropin- secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 85: 1487-1491